issued by the Government of India in the Ministry of Chemicals and Fertilizers the National Pharmaceutical Pricing Authority

jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99 vlk/kj.k EXTRAORDINARY Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii) izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY la- 2081] ubZ fnYyh] cq/okj] tqykbZ 3] 2019@vk"kk<+ 12] 1941 No. 2081] NEW DELHI, WEDNESDAY, JULY 3, 2019/ ASHADHA 12, 1941 jlk;u vkSj moZjd ea=ky; ¼vkS"k/k foHkkx½ ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ vkns’k ub Z fnYyh] 3 tyq kb]Z 2019 dk- vk- 2300¼v½-&Hkkjr ljdkj d s jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 eb]Z 2013 vkSj dk- vk- 701¼v½ rkjh[k 10 ekp]Z 2016 d s lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk inz Rr 'kfDr;k sa dk i;z kxs djrs g,q ] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k ¼ftldk s lfa{kIr :i e sa ,uihih, dgk tkrk g½S] uhp s dh lkj.kh d s LrHa k ¼6½ e as fofufn"ZV [knq jk eYw ; dk s mDr lkj.kh d s LrHa k ¼3½] ¼4½ vkSj ¼5½ e as rRLFkkuh ifzof"V;ksa e sa fofufn"ZV icz yrk] bdkb Z ¼;wfuV½ vkSj fofuekZrk vkSj foi.ku dEifu;k sa d s uke lfgr LrHa k ¼2½ e sa dh rRLFkkuh izfof"V es a l s iRz ;ds dh] oLr q ,o a lsok dj] ;fn dkbs Z gS] dk s NkMs d+ j vf/kdre [knq jk ewY; d s :i e sa fu;r djrh gSA lkj.kh Ø- vuqlwfpr fofufefZr icz yrk bdkb Z fofuekZrk vkSj foi.ku dia uh [knq jk l-a dk uke@czkMa dk eYw ;¼#-½ uke ¼1½ ¼2½ ¼3½ ¼4½ ¼5½ ¼6½ 1- eQs us fed ,flM $ iRz ;ds xkys h e%sa eSll Z fØl Qkek Z ¼bfaM;k½ 2-76 isjkflVkekys xkys h eQs us fed ,flM vkbiZ h 500 fexzk-] 1 xkys h fy-@eSll Z lhxyq isjkflVkekys vkbiZ h 325 fexzk- QkekZL;wfVdYl izk- fy- 2- eQs us fed ,flM $ iRz ;ds 5 fefy- lLi“sa ku e%sa eSll Z fØl Qkek Z ¼bfaM;k½ 0-63 isjkflVkekys lLi“sa ku eQs us fed ,flM vkbiZ h 100 fexzk-] 1 fefy- fy-@eSll Z lhxyq isjkflVkekys vkbiZ h 250 fexzk- QkekZL;wfVdYl izk- fy- 3- XyhefsijkbM $ iRz ;ds vfyfir fcy;s M Z xkys h e%sa 1 xkys h eSll Z foMa ykl ck;kVs ds izk 8-75 eVs QkWfeuZ xkys h XyhefsijkbM vkbiZ h 2 fexzk-] fy-@eSll Z tqoVsa l gYs Fkd;s j eVs QkWfeuZ gkbMZ ªksDyksjkbM vkbiZ h fy- 3316 GI/2019 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 1000 fexzk- ¼izkys kWxM fjfyt e½sa 4- XyhefsijkbM $ iRz ;ds vfyfir fcy;s M Z xkys h e%sa 1 xkys h 5-46 eSll Z fLol xkfu;Z j eVs QkWfeuZ xkys h XyhefsijkbM vkbiZ h 1 fexzk-] ck;kVs ds @eSll Z tqoVsa l eVs QkWfeuZ gkbMZ ªksDyksjkbM vkbiZ h 500 gYs Fkd;s j fyfeVMs fexzk- ¼lLVMsa fjfyt e½sa 5- XyhefsijkbM $ iRz ;ds vfyfir fcy;s M Z xkys h e%sa 1 xkys h 7-96 eSll Z fLol xkfu;Z j eVs QkWfeuZ xkys h XyhefsijkbM vkbiZ h 2 fexzk-] ck;kVs ds @eSll Z tqoVsa l eVs QkWfeuZ gkbMZ ªksDyksjkbM vkbiZ h 500 gYs Fkd;s j fyfeVMs fexzk- ¼lLVMsa fjfyt e½sa 6- ,fLdVkykis zke $ iRz ;ds fQYe fyfir xkys h e%sa 1 xkys h 6-24 Dykus tis ke xkys h ,fLdVkykis zke vkWDlkyVs d s cjkcj eSll Z bjht ykbQlkbal fy ,fLdVkykis zke 5 fexzk-] Dykus tis ke vkbiZ h 0-5 fexzk- 7- Vys felkVuZ $ iRz ;ds fQYe fyfir xkys h e%sa 1 xkys h eSll Z lu Qkek Z ycs ksjVs jht 8-21 DyksjFkkyhMkus xkys h Vys felkVuZ vkbiZ h 40 fexzk-] fy-@eSll Z lu DyksjFkkyhMkus vkbiZ h 12-5 fexzk- QkekZL;wfVdYl bMa LVªht fy- 8- XyhefsijkbM $ iRz ;ds vfyfir fcy;s M Z xkys h e%sa 1 xkys h 6-57 eSll Z foMa ykl ck;kVs ds izk- eVs QkWfeuZ xkys h XyhefsijkbM vkbiZ h 1 fexzk-] fy-@eSll Z tqoVsa l gYs Fkd;s j eVs QkWfeuZ gkbMZ ªksDyksjkbM vkbiZ h fy- 1000 fexzk- ¼izkys kWxM fjfyt e½sa 9- fXyDyktkbM $ iRz ;ds vfyfir xkys h e%sa 1 xkys h 6-65 eVs QkWfeuZ xkys h fXyDyktkbM vkbiZ h 80 fexzk-] eSll Z vuQj vkWxfsZuDl izk- eVs QkWfeuZ gkbMªksDyksjkbM vkbiZ h 500 fy-@eSll Z yfqiu fy- fexzk- uksV % ¼d½ mi;DqZ r nh xb Z fofufn"ZV QkWeywZ 's ku d s fofuekZrk vFkkZr tk s Þub Z Mxª ß Mhihlhvk]s 2013 d s iSjkxzkQ 2¼;½w d s rgr mi;qZDr nh xb Z lkj.kh d s LrHa k ¼6½ e sa fofufn"ZV [knq jk eYw ; fu/kkZfjr djxsa sA ¼[k½ vxj fuekZrkvk sa u s mi;qZDr lkj.kh d s LrHa k ¼6½ e sa of.kZr vf/kdre dher ij ljdkj dk s okLro e sa Hkxq rku fd;k gS ;k ;g n;s gS rk s o s oLr q ,o a lsok dj dk s tkMs + ldr s gSAa ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkn's k] 2013 d s iSjkxzkQ 11 e sa fn, x, izko/kkuks a d s rgr fuekZrkvksa dk s mi;qZDr lkj.kh d s LrHa k ¼6½ e sa fofufn"ZV [knq jk eYw ; d s vk/kkj ij vuqlwfpr fofufeZfr;k sa d s iSdk sa d s fy, [knq jk eYw ; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 d s iSjkxzkQ 24 d s rgr QkWe Z V esa vf/klpw uk dh rkjh[k l s ,d eYw ; lpw h ,uihih, dk s vkbiZ hMh,e,l d s ek/;e l s tkjh djs a rFkk mldh dkWih jkT; vkS"kf/k fu;a=dk sa vkSj fofuekZrk forjdk sa dk s tkjh djsaA ¼?k½vkS"k/k ¼ewY; fu;a=.k½ vkn's k] 2013 d s 24 ¼4½ d s mic/a kk sa ds vuqlkj iRz ;ds QVq dj foØsrk vkSj forjd fofuekZrk }kjk fn, x, :i e sa ,sl s ifjlj] tgk a dkjckj dk s bl idz kj fd;k tk jgk gS fd mll s ijke“k Z d s bPNdq fdlh O;fDr d s fy, igpqa vklku gk]s ogk a mld s fdlh lgtn“` ; Hkkx ij dher lpw h vkSj iwjd lpw h] ;fn dkbs Z gk]s dks lia nz f“kZr djxs kA ¼M-½ mi;DqZ r xSj vf/kdre dher ¼[knq jk eYw ;½ dsoy mi;DqZ r fuekZrk@foi.ku d s fy, ykx w gS tSlk fd mUgkusa s vkS"k/k ¼ewY; fu;a=.k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkZj.k@l'a kks/ku d s fy, QkWe Z I ij tek fd;k x;k Fkk vkSj ljdkj }kjk fu/kkfZjr lHkh ykx w oS/kkfud vko';drkvks a dh ifwr Z d s v/khu izklfaxd fof/k;k@sa fu;eks a d s vUrxZr tSlk fd dUsnzh;@jkT; ykblfslxa vkWFkksfjVh d s l{ke izkf/kdkjh }kjk eUs;Qw sDpfjxa ykblsal eta jw h d s rgr lca fa/kr fofufeZr fuekZrk@foi.ku dEifu;k a tk s vuiq kyu djrh gSA ¼p½ fofuekZrk ;k foi.ku dEiuh] mijksDr fofufeZfr;ks a vkSj fofufn"ZV 'krks± dk ikyu ugh a djrh gS a rk s o s vko';d oLrq,¡ vf/kfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk sa d s v/khu C;kt lfgr vf/kiHz kkfjr jkf'k dk s tek dju s d s fy, nk;h gkxsa As ¼N½ bl vkn's k es a mijksDr lkj.kh d s LrHa k ¼2½ e sa dh rRLFkkuh ifzof"V e sa fofufn"ZV fofufeZfr;k sa d s iSdk sa dh [kqnjk eYw ; fu;r gkus s d s ifj.kkeLo#i] vkn's k tk s fd bl vkn's k l s iow Z tkjh gq, g]S Lor% gh fujLr gk s tk;saxsA [dk-al-a@200@68@2019@,Q@Qk- l-a 8¼68½@2019@Mhih@,uihih,&fMoh-&II] izlus thr nkl] lgk;d fun's kd¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 3rd July, 2019 S.O.2300(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE Sl. Name of the Strength Unit Manufacturer & Retail No. Formulation / Marketing Company Price Brand Name (Rs.) (1) (2) (3) (4) (5) (6) 1. Mefenamic acid + Each tablet contains: M/s Cris Pharma (India) 2.76 Paracetamol tablet Mefenamic acid IP 500mg, 1 Tablet Ltd. / M/s Seagull Paracetamol IP 325mg Pharmaceuticals Pvt. Ltd. 2. Mefenamic acid + Each 5ml Suspension contains: M/s Cris Pharma (India) 0.63 Paracetamol Mefenamic acid IP 100mg, 1 ML Ltd. / M/s Seagull Suspension Paracetamol IP 250mg Pharmaceuticals Pvt. Ltd. 3. Glimepiride + Each uncoated bilayered tablet 8.75 Metformin Tablet contains: M/s Windlas Biotech Pvt. Glimepiride IP 2mg 1 Tablet Ltd. / M/s Zuventus Metformin Hydrochloride IP Healthcare Limited 1000mg (in prolonged release form) 4. Glimepiride + Each uncoated bilayered tablet 5.46 Metformin tablet contains: M/s Swiss Garnier Glimepiride IP 1mg 1 Tablet Biotech / M/s Zuventus Metformin Hydrochloride IP 500mg Healthcare Limited (in Sustain Release) 5. Glimepiride + Each uncoated bilayered tablet 7.96 Metformin tablet contains: M/s Swiss Garnier Glimepiride IP 2mg 1 Tablet Biotech / M/s Zuventus Metformin Hydrochloride IP 500mg Healthcare Limited (in Sustain Release) 6. Escitalopram + Each film coated tablet contains: 6.24 Clonazepam tablet Escitalopram Oxalate IP eq. to 1 Tablet M/s Eris Lifesciences Ltd. Escitalopram 5mg, Clonazepam IP 0.5mg 7. Telmisartan + Each film coated tablet contains: M/s Sun Pharma 8.21 Chlorthalidone tablet Telmisartan IP 40mg, Laboratories Limited / 1 Tablet Chlorthalidone IP 12.5mg M/s Sun Pharmaceuticals Industries Limited 8. Glimepiride + Each uncoated bilayered tablet 6.57 Metformin Tablet contains: M/s Windlas Biotech Pvt. Glimepiride IP 1mg 1 Tablet Ltd. / M/s Zuventus Metformin Hydrochloride IP Healthcare Limited 1000mg (in prolonged release form) 9. Gliclazide + Each un coated tablet contains: 6.65 M/s Anphar Organics Pvt. Metformin Tablet Gliclazide IP 80mg 1 Tablet Ltd. / M/s Lupin Limited Metformin Hydrochloride IP 500mg Note: (a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/200/68/2019/F/F. No. 8(68)/2019/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.